Minolira Extended Release
Product manufactured by Epi Health, Inc
Indications and Purposes
1 Indications And Usage Minolira Is Indicated To Treat The Inflammatory Lesions Of Non-Nodular Moderate To Severe Acne Vulgaris In Patients 12 Years Of Age And Older. Minolira Is A Tetracycline-Class Drug Indicated To Treat Only Inflammatory Lesions Of Non-Nodular Moderate To Severe Acne Vulgaris In Patients 12 Years Of Age And Older. ( 1 ) Limitations Of Use This Formulation Of Minocycline Has Not Been Evaluated In The Treatment Of Infections. To Reduce The Development Of Drug-Resistant Bacteria As Well As To Maintain The Effectiveness Of Other Antibacterial Drugs, Minolira Should Be Used Only As Indicated [See Warnings And Precautions (5.13) ]. Limitations Of Use This Formulation Of Minocycline Has Not Been Evaluated In The Treatment Of Infections. To Reduce The Development Of Drug-Resistant Bacteria As Well As To Maintain The Effectiveness Of Other Antibacterial Drugs, Minolira Should Be Used Only As Indicated [See Warnings And Precautions (5.13) ] . |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Minocycline Hydrochloride |
|
ZINC14879992 |